CCS
Buying intent
26 tracked signals | Top 15 topics are below | Sales is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere CCS's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
10d ago
19d ago
10d ago
10d ago
20d ago
20d ago
17d ago
20d ago
20d ago
17d ago
17d ago
17d ago
10d ago
28d ago
25d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at CCS
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
Primary products / business lines
LinkedIn company profileCCS is a leading provider of collaborative care programs and home-delivered medical supplies for those with chronic conditions, specifically diabetes. With CCS as their partner, patients are more likely to get on therapy and stay on therapy – reducing costs and improving outcomes. Our mission is to redefine at-home patient care for people living with chronic conditions by providing not only medic
Top accounts researching CCS
names withheld on the public pageThese are companies whose own people brought up CCS unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
24,131 companies · 93,859 people are researching Leadership Development
CCS's own team shows 2 signals on this topic. No one outside CCS has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- High-impact system6,390 cos · 20,106 people
- Team Building6,006 cos · 19,016 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 2 people; Leadership — 2 people
What's been said
public posts by CCS's teamNo public post naming CCS has surfaced in the past year, so this is what CCS's own team is posting about publicly — their topics, in their words.
Looking forward to attending ISPOR—The Professional Society for Health Economics and Outcomes Research 2026 in Philadelphia next week. CCS will be sharing findings from our randomized study evaluating how structured coaching and education at the time of CGM initiation impacts glycemic and patient-reported outcomes. One of the recurring themes in diabetes care is that CGM access alone is not enough. How individuals are supported in the first weeks and months after therapy initiation matters. If you’ll be at ISPOR, I’d love to connect and invite you to stop by our poster. Jason Allaire
May 2026CMS is continuing to modernize the prior authorization process for DMEPOS suppliers — and that could be a big win for both patients and providers. 👏 Recent CMS updates are designed to streamline prior authorizations, reduce administrative burden, and reward suppliers with strong compliance records through a potential “gold carding” exemption process. Suppliers with high provisional affirmation rates may eventually qualify for fewer prior authorization requirements. Here are important dates to take note of: June 1, 2026 — First annual “gold carding” exemption cycle officially begins for qualifying DME suppliers. January 1, 2027 — CMS electronic prior authorization API requirements go live for impacted payers. This is the major interoperability milestone many providers and suppliers are preparing for now. October 1, 2027 — Proposed compliance date for expanded electronic prior authorization rules, including drug-related prior authorization workflows and new decision timelines. This is where experienced DME partners can truly make a difference. Companies like CCS Medical have built entire teams around navigating insurance requirements, documentation workflows, and patient support for diabetes care. As CMS continues evolving these programs, suppliers that invest in compliance, education, and proactive communication will be positioned to better serve both providers and patients. The healthcare industry talks a lot about “patient-centered care” — but simplifying access to medically necessary supplies is one of the most impactful ways to deliver it. The future of DME isn’t just about shipping supplies. It’s about: 📈 Operational excellence 🤝 Provider collaboration 📚 Patient education ⚡ Speed to therapy And ultimately, helping people manage chronic conditions with fewer barriers. Excited to see CMS taking steps toward a smarter and more efficient authorization process for the DME industry. #DME #DiabetesCare #CGM #Medicare #PriorAuthorization #HealthcareInnovation #CCSMedical #ChronicCare #MedicalSupplies #HealthcareLeadership
May 2026Cardiovascular disease remains one of the leading causes of complications and death for people living with diabetes. Appreciate the American Heart Association continuing to elevate the importance of cardiometabolic care through initiatives like Outpace CVD. #LivingConnected was designed to support cardiometabolic health through blood pressure support, weight management, lifestyle coaching, medication adherence, and ongoing education alongside CGM therapy. I especially appreciate the focus on helping organizations evaluate their current approach to diabetes care and identify potential gaps in support, education, and follow-up over time. #DiabetesCare #CardiovascularDisease #ASCVD #PopulationHealth
May 2026